Norwich Pharmaceuticals, Inc. has made several appointments as part of the company’s initiative to expand its contract manufacturing and packaging services. Douglas L. Drysdale has been appointed to the newly created position of chief executive officer and Thomas Salus and Robert Klehr will be responsible for new business development. Mr. Salus and Mr. Klehr will be based in NJ and will share responsibility for covering the U.S.     Mr. Drysdale most recently served as vice president, ...